Boston, MA, United States of America

Brenda K Eustace

This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Vertex Pharmaceuticals, Inc.. Active years: 2024-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Brenda K Eustace. Retrieved from https://idiyas.com/inventor/brenda-k-eustace-mz3tkl6n

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0

Average Co-Inventor Count = 5.3

ph-index = 1


Company Filing History:


Years Active: 2024-2025

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Brenda K Eustace: Innovator in Hemoglobinopathies Treatment

Introduction

Brenda K Eustace is a prominent inventor based in Boston, MA. She has made significant contributions to the field of biotechnology, particularly in the treatment of hemoglobinopathies. Her innovative work has led to the development of groundbreaking methods that have the potential to improve patient outcomes.

Latest Patents

Brenda holds a patent titled "Compositions and Methods for Editing Beta-Globin for Treatment of Hemoglobinopathies." This patent represents her commitment to advancing medical science and providing solutions for individuals affected by blood disorders. She has 1 patent to her name, showcasing her expertise and dedication to her field.

Career Highlights

Brenda is currently employed at Vertex Pharmaceuticals, Inc., a leading company in the biotechnology sector. Her role at Vertex allows her to collaborate with other talented professionals and contribute to innovative research and development projects.

Collaborations

Throughout her career, Brenda has worked alongside notable colleagues, including Sanjay D'souza and Jason West. These collaborations have further enriched her research and have played a crucial role in the advancement of her projects.

Conclusion

Brenda K Eustace is a remarkable inventor whose work in the treatment of hemoglobinopathies is paving the way for future innovations in biotechnology. Her contributions are vital to the ongoing efforts to improve health outcomes for patients with blood disorders.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…